Successful osimertinib rechallenge without concomitant corticosteroids after osimertinib-induced pneumonitis

A 60-year-old woman was diagnosed with cT4N3M1c stage IVB lung adenocarcinoma with epidermal growth factor receptor mutation of exon19 deletion. After one month of treatment with osimertinib, a cough and diffuse ground glass opacities were observed in the bilateral lung field. Based on the clinical...

Full description

Bibliographic Details

Published in:	Respiratory Medicine Case Reports
Main Authors:	Taisuke Ito, Kazuo Tsuchiya, Rie Mori, Takuro Akashi, Yoshiyuki Oyama, Masaki Ikeda
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Osimertinib Osimertinib-induced pneumonitis Re-administration Desensitization EGFR-TKI
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007124000522